Payment overview · 2025
General Payments
$125.00
1 reported records · 1 companies
Healthcare provider profile · identity verified
Amir Aref
Allopathic & Osteopathic Physicians|Internal Medicine · TACOMA, WA · NPI 1063522126
Verified facts
What the public records show
CMS Open Payments records show Amir Aref received $125.00 in general payments during 2025 across 1 reported records.
Bayer Healthcare Pharmaceuticals Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $125.00 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $125.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $125.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 884 | 190 |
| Levothyroxine Sodium | Levothyroxine Sodium | 588 | 85 |
| Eliquis | Apixaban | 488 | 58 |
| Gabapentin | Gabapentin | 394 | 89 |
| Amlodipine Besylate | Amlodipine Besylate | 324 | 84 |
| Metoprolol Succinate | Metoprolol Succinate | 303 | 80 |
| Furosemide | Furosemide | 273 | 62 |
| Tamsulosin Hcl | Tamsulosin Hcl | 250 | 56 |
| Trazodone Hcl | Trazodone Hcl | 235 | 50 |
| Lisinopril | Lisinopril | 225 | 55 |
| Pantoprazole Sodium | Pantoprazole Sodium | 220 | 60 |
| Potassium Chloride | Potassium Chloride | 213 | 42 |
| Jardiance | Empagliflozin | 211 | 26 |
| Metformin Hcl | Metformin Hcl | 211 | 41 |
| Warfarin Sodium | Warfarin Sodium | 199 | 13 |
| Clopidogrel | Clopidogrel Bisulfate | 194 | 45 |
| Metoprolol Tartrate | Metoprolol Tartrate | 187 | 43 |
| Losartan Potassium | Losartan Potassium | 173 | 47 |
| Duloxetine Hcl | Duloxetine Hcl | 172 | 34 |
| Buspirone Hcl | Buspirone Hcl | 167 | 39 |
| Torsemide | Torsemide | 150 | 39 |
| Baclofen | Baclofen | 147 | 29 |
| Carvedilol | Carvedilol | 143 | 39 |
| Xarelto | Rivaroxaban | 142 | 32 |
| Quetiapine Fumarate | Quetiapine Fumarate | 137 | 37 |
| Famotidine | Famotidine | 129 | 35 |
| Levetiracetam | Levetiracetam | 127 | 24 |
| Sertraline Hcl | Sertraline Hcl | 125 | 35 |
| Citalopram Hbr | Citalopram Hydrobromide | 114 | 24 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 97 | 19 |
| Donepezil Hcl | Donepezil Hcl | 97 | 22 |
| Hydralazine Hcl | Hydralazine Hcl | 95 | 29 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 94 | 24 |
| Fluoxetine Hcl | Fluoxetine Hcl | 93 | 24 |
| Omeprazole | Omeprazole | 86 | 32 |
| Fluticasone Propionate | Fluticasone Propionate | 84 | 26 |
| Metformin Hcl Er | Metformin Hcl | 82 | 20 |
| Mirtazapine | Mirtazapine | 78 | 28 |
| Spironolactone | Spironolactone | 78 | 24 |
| Divalproex Sodium | Divalproex Sodium | 76 | 17 |
| Simvastatin | Simvastatin | 76 | 15 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 74 | 16 |
| Prednisone | Prednisone | 73 | 24 |
| Hydrochlorothiazide | Hydrochlorothiazide | 70 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 69 | 19 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 68 | 37 |
| Escitalopram Oxalate | Escitalopram Oxalate | 68 | 14 |
| Finasteride | Finasteride | 67 | 16 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 66 | 13 |
| Olanzapine | Olanzapine | 65 | suppressed |
| Allopurinol | Allopurinol | 63 | 22 |
| Atenolol | Atenolol | 63 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 63 | 18 |
| Diclofenac Sodium | Diclofenac Sodium | 61 | 29 |
| Midodrine Hcl | Midodrine Hcl | 58 | 18 |
| Alendronate Sodium | Alendronate Sodium | 57 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 57 | 31 |
| Oxycodone Hcl | Oxycodone Hcl | 56 | 22 |
| Entresto | Sacubitril/Valsartan | 55 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 53 | 53 |
| Risperidone | Risperidone | 53 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 53 | 17 |
| Myrbetriq | Mirabegron | 49 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 48 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 48 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 47 | 21 |
| Pravastatin Sodium | Pravastatin Sodium | 47 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 45 | 11 |
| Lovastatin | Lovastatin | 44 | suppressed |
| Zonisamide | Zonisamide | 42 | suppressed |
| Latanoprost | Latanoprost | 41 | 16 |
| Amiodarone Hcl | Amiodarone Hcl | 40 | 13 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 40 | 39 |
| Aripiprazole | Aripiprazole | 40 | suppressed |
| Budesonide | Budesonide | 40 | suppressed |
| Nifedipine Er | Nifedipine | 40 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 40 | suppressed |
| Hydrocortisone | Hydrocortisone | 39 | 12 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 38 | 22 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 37 | 24 |
| Tradjenta | Linagliptin | 37 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 36 | suppressed |
| Trulicity | Dulaglutide | 36 | suppressed |
| Memantine Hcl | Memantine Hcl | 35 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 34 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 34 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 34 | suppressed |
| Topiramate | Topiramate | 33 | suppressed |
| Bupropion Xl | Bupropion Hcl | 32 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 32 | suppressed |
| Sucralfate | Sucralfate | 32 | suppressed |
| Glipizide | Glipizide | 30 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Chlorthalidone | Chlorthalidone | 28 | suppressed |
| Januvia | Sitagliptin Phosphate | 28 | suppressed |
| Creon | Lipase/Protease/Amylase | 27 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 27 | suppressed |
| Insulin Lispro | Insulin Lispro | 27 | suppressed |
| Carbamazepine | Carbamazepine | 26 | suppressed |
| Clonidine | Clonidine | 26 | suppressed |
| Ondansetron Odt | Ondansetron | 26 | 21 |
| Tizanidine Hcl | Tizanidine Hcl | 26 | suppressed |
| Verapamil Er | Verapamil Hcl | 25 | suppressed |
| Brilinta | Ticagrelor | 24 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 24 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 23 | 18 |
| Prazosin Hcl | Prazosin Hcl | 23 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 22 | suppressed |
| Ozempic | Semaglutide | 22 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 21 | 15 |
| Flecainide Acetate | Flecainide Acetate | 21 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 21 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 20 | suppressed |
| Pregabalin | Pregabalin | 20 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 19 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 19 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 19 | suppressed |
| Digoxin | Digoxin | 19 | suppressed |
| Lamotrigine | Lamotrigine | 19 | suppressed |
| Acyclovir | Acyclovir | 18 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 18 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 18 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 18 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 18 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 17 | suppressed |
| Carbamazepine Er | Carbamazepine | 17 | suppressed |
| Cephalexin | Cephalexin | 17 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 17 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 17 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 17 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 17 | 13 |
| Lorazepam | Lorazepam | 17 | suppressed |
| Nystatin | Nystatin | 17 | 12 |
| Bupropion Hcl | Bupropion Hcl | 16 | suppressed |
| Calcitriol | Calcitriol | 16 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 16 | suppressed |
| Lacosamide | Lacosamide | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 16 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 15 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 15 | 12 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 15 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 15 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 15 | suppressed |
| Novolog | Insulin Aspart | 15 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 15 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 14 | suppressed |
| Calcium Acetate | Calcium Acetate | 14 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Levofloxacin | Levofloxacin | 14 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 14 | suppressed |
| Rybelsus | Semaglutide | 14 | suppressed |
| Atovaquone | Atovaquone | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Xifaxan | Rifaximin | 13 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | 12 |
| Fenofibrate | Fenofibrate Nanocrystallized | 12 | suppressed |
| Lactulose | Lactulose | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Tacrolimus | Tacrolimus | 12 | suppressed |
| Cholestyramine Light | Cholestyramine | 11 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 11 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Haloperidol | Haloperidol | 11 | suppressed |
| Ibuprofen | Ibuprofen | 11 | suppressed |
| Irbesartan | Irbesartan | 11 | suppressed |
| Letrozole | Letrozole | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $125.00 · 1 records | Bayer Healthcare Pharmaceuticals Inc. | Kerendia | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error